Competition investigation on pharmaceutical companies

The Competition Board (RK) decided to open an investigation against 19 companies, most of which operate in the pharmaceutical industry, to determine whether competition has been violated.

In the statement from the Competition Authority, “It was resolved, dated 09/11/2023 and numbered 23-53/1004-M, to open an investigation against 19 companies in order to determine whether Law No. 4054 on the Protection of Competition has been violated by companies operating in the pharmaceutical sector and some other sectors.

According to the statement on the institution’s website; The initiatives in question are the following:

* AbbVie Limited Company for Industry and Trade of Medical Drugs,

* Abdi İbrahim İlaç Sanayi and Ticaret Anonim Şirketi,

* AstraZeneca Pharmaceutical Industry and Commerce Joint Stock Company,

* BASF Turkish Chemical Industry and Trade Joint Stock Company,

* Bausch & Lomb Public Limited Company for the Marketing of Optical and Health Products,

* Bayer Turkish Chemical Industry Limited Company,

* GlaxoSmithKline Pharmaceutical Commerce and Industry Joint Stock Company,

* İlko İlaç Sanayi and Ticaret Anonim Şirketi,

* Johnson and Johnson Sanitary Material Industry and Trade Limited Company,

* Liba Laboratories Joint Stock Company,

* Public Limited Company of Commerce of the Pharmaceutical and Health Industry Menarini,

* Merck Pharmaceuticals Public Limited Company of Pharmaceutical and Chemical Products,

*Merck Sharp Dohme Pharmaceuticals Company Limited,

* Michael Page International Nem Employment Consultancy Limited Company

*Panasonic Electronic Sales Joint Stock Company,

* Pfizer PFE Pharmaceutical Products Joint Stock Company,

* Sanofi Pharmaceutical Commerce and Industry Joint Stock Company,

* Joint Stock Company of Pharmaceutical Products SIFI,

* World Medicine Pharmaceutical Trade and Industry Joint Stock Company